1. Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab vs. Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
   Huabin Hu et al, 2020, Frontiers in Oncology CrossRef
2. Clinical value of lncRNA SOX2-OT in pulmonary arterial hypertension and its role in pulmonary artery smooth muscle cell proliferation, migration, apoptosis, and inflammatory
   Yunfei Jiang et al, 2022, Heart & Lung CrossRef
3. Integrative bioinformatics analysis reveals ECM and nicotine-related genes in both LUAD and LUSC, but different lung fibrosis-related genes are involved in LUAD and LUSC
   Marzyeh Alipour et al, 2024, Nucleosides, Nucleotides & Nucleic Acids CrossRef
4. Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer with PD-L1 tumor proportion score 1% or greater
   Longjiang She et al, 2019, Lung Cancer CrossRef
5. LncRNA FOXD2‐AS1 as a competitive endogenous RNA against miR‐150‐5p reverses resistance to sorafenib in hepatocellular carcinoma
   Chengjun Sui et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
6. Identification of New Potential LncRNA Biomarkers in Hirschsprung Disease
   Ana Torroglosa et al, 2020, International Journal of Molecular Sciences CrossRef
7. The prognostic value of long noncoding RNA Sox2ot expression in various cancers: A systematic review and meta-analysis
   Xiaoyang Song et al, 2018, Clinica Chimica Acta CrossRef
8. SOX2OT, a novel tumor-related long non-coding RNA
   Ying Wang et al, 2020, Biomedicine & Pharmacotherapy CrossRef
9. Cost-Effectiveness Analysis of Atezolizumab Plus Chemotherapy in the First-Line Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer
   Dong Ding et al, 2020, Advances in Therapy CrossRef
10. Circulating long non‐coding RNA GAS5 and SOX2OT as potential biomarkers for diagnosis and prognosis of non‐small cell lung cancer
    Lamiaa M. Kamel et al, 2019, Biotechnology and Applied Biochemistry CrossRef
11. LINK‑A lncRNA is upregulated in metastatic non‑small cell lung cancer and is associated with poor prognosis
    Junqiang Liu et al, 2019, Oncology Letters CrossRef
12. Functional Peptides Encoded by Long Non-Coding RNAs in Gastrointestinal Cancer
    Yao Chen et al, 2021, Frontiers in Oncology CrossRef
13. Prognostic value of long non-coding RNA SNHG20 in cancer
    Jiling Zeng et al, 2020, Medicine CrossRef
14. Effects of conditioned media from murine lung cancer cells and human tumor cells on cultured myotubes
    Blas A. Guigni et al, 2020, American Journal of Physiology-Endocrinology and Metabolism CrossRef